Announcements
Research Awards and Information
Dr. Vladimir Badovinac received a notice of R01 funding from the National Institutes of Health. The title of the project is Memory CD8 T Cell Responses After Multiple Antigen Encounters. This award is for the period of July 1, 2009 through June 30, 2013. The amount of this award is $1,487,450.
Dr. Gary Baumbach has a new award from the American Heart Association, Midwest Affiliate for a research project titled Roles of PPARgamma and EGFR Transactivation in Angiotensin II-Induced Remodeling of Cerebral Arterioles. The award total is $143,000. This award is for the period of July 1, 2009 through June 30, 2011.
Dr. Aaron Bossler received a Holden Comprehensive Cancer Center’s institutional Research Grant from the American Cancer Society for a research project titled Role of Protein Tyrosine Phosphatase, PTPN13, in Cervical Squamous Cell Carcinoma The award total is $30,000. This grant is for the period of September 1, 2009 through August 31, 2010.Dr. Aaron Bossler has a new research contract negotiated with Roche Molecular Systems, Inc. for a research project titled Early Evaluation of the New Cobas 4800 Instrument System. The contract total is $39,161. This contract is for the period of April 20, 2009 through August 1, 2009.
Dr. Aaron Bossler along with Dr. Aloysius Klingelhutz in Microbiology have received a new collaborating research contract with Dr. John Lee from Sanford Research/USD. The title of this project is Mechanisms of Invasion for an HIV Related Head and Neck Cancer. This collaboration through June 30, 2012 will bring an estimated support in the amount of $194,992 for this collaborative effort.
Dr. Michael Cohen has received a continuation of a collaborating research contract with Dr. Pradip Roy-Burman from the University of Southern California. The title of this project is Pathogenesis and Progression of Prostate Cancer. The continuation will extend this collaboration through May 31, 2013 and will bring an estimated additional support in the amount of $398,067 for this collaborative effort.
Dr. Robert Cook received a notice of R01 funding from the National Institutes of Health. The title of the project is Chronic Alcohol Abuse Disrupts CD8+ T Cell Function. This award is for the period of September 25, 2009 through August 31, 2014. The amount of this award is $1,347,845.
Dr. Fred Dee received a notice of educational development funding from the University of Iowa Carver College of Medicine, Office of the Consultation and Research in Medical Education. The title of the project is Development and Assessment of a Web-based Pathogenesis Diagramming Program. This award is for the period of July 1, 2009 through December 31, 2010. The amount of this award is $10,000.
Dr. Daniel Diekema has a new research contract negotiated with bioMérieux, Inc. for a research project titled AF02 Antifungal Susceptibility Tests Clinical Trial and Equivalency Trial Protocol: Vitek2 and Vitek2 Compact. The contract total is $53,653. This contract is for the period of August 28, 2009 through August 24, 2010.Dr. Benjamin Darbro received a 2009 Resident Research Grant from the College of American Pathologists (CAP) Foundation for a research project titled In Silico and Experimental Analysis of a Novel Intronic LMNA DNA Variation Implicated in Limb Girdle Muscular Dystrophy Type IB and Dilated Cardiomyopathy. This award total is $2,500 and is for the period of October 1, 2009 through October 31, 2010.
Dr. Fiorenza Ianzini has received a notice of a cost extension from NASA for her research project titled Role of High-LET Radiation-induced Mitotic Catastrophe in Mutagenesis: Implication for Carcinogenesis. The cost extension award is for $297,440, bringing the total award for this NASA project to $1,197,440. This research project is for the period of December 1, 2006 through November 30, 2010.
Dr. Siegfried Janz was awarded the 2009 Donald D. Dorman Research Award for his lymphoma research in the amount of $2,500. The Holden Comprehensive Cancer Center awarded two prizes for the best research papers in leukemia and lymphoma published in 2007-2008 from the Donald D. Dorfman Endowment. One award is made to an investigator in the area of basic laboratory research and one to an investigator in the area of clinical research, including population science.
Dr. Tomomi Kuwana received a notice of R01 funding from the National Institutes of Health. The title of the project is Mitochrondrial Regulation of Apoptosis. This award is for the period of September 30, 2009 through August 31, 2014. The amount of this award is $1,425,000.Dr. Kevin Legge received a notice of R01 ARRA funding from the National Institutes of Health. The title of the project is Chronic alcohol and pulmonary immunity. This award is for the period of August 20, 2009 through July 31, 2011. The amount of this award is $611,004.
Dr. Steven Moore has a new research agreement negotiated with PTC Therapeutics, Inc. for a research project titled Ataluren (PTC124). The award total is $189,008. This research agreement is for the period of September 24, 2009 through April 28, 2010.
Dr. Steven Moore has a new award from the Jain Foundation, Inc. for a research project titled Dysferlin Antibodies. The award total is $8,587. This award is for the period of July 1, 2009 through June 30, 2010.
Dr. Peter Nagy received a notice of R01 ARRA Administrative Supplement funding from the National Institutes of Health. The title of the project is Pathogenesis of Neurodegenerative Diseases Caused by Mutations in Senataxin. This award is for the period of September 30, 2009 through August 31, 2011. The amount of this additional funding is $172,594.
Dr. Vishala Neppalli received a research contract negotiated with the National Institutes of Health. The title of the project is Defining Molecular Subtypes of Follicular Lymphoma for Relevance to Survival, Etiology, and Diagnosis. This award is for the period of September 30, 2009 through September 29, 2010. The amount of this award is $16,704.
Dr. Annette Schlueter received a Holden Comprehensive Cancer Center’s Aiming for a Cure Foundation grant award for a research project titled Regulatory Dendritic Cell Therapy for Acute Graft vs. Host Disease. This award total is $50,000 and is for the period of October 1, 2009 through September 30, 2011.
Dr. Thomas Waldschmidt received a notice of R01 ARRA funding from the National Institutes of Health. The title of the project is Chronic ethanol, B cell competence and lymphoid integrity. This award is for the period of August 20, 2009 through July 31, 2011. The amount of this award is $1,302,240.